Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00500_DB01432_nanopub.RAJ2d_ICSSMl95nLJFpV_FrTJeJPEt-K31-Pz_-HPU9Zg#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00500_DB01432 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00500_DB01432 label "DDI between Tolmetin and Cholestyramine - Cholestyramine may decrease the absorption of Tolmetin. Monitor for changes in the therapeutic and adverse effects of Tolmetin if Cholestyramine is initiated, discontinued or dose changed. Spacing administration by at least 2 hours may reduce the risk of interaction. [drugbank_resource:DB00500_DB01432]" assertion.
- drugbank_resource:DB00500_DB01432 identifier "drugbank_resource:DB00500_DB01432" assertion.
- drugbank_resource:DB00500_DB01432 title "DDI between Tolmetin and Cholestyramine - Cholestyramine may decrease the absorption of Tolmetin. Monitor for changes in the therapeutic and adverse effects of Tolmetin if Cholestyramine is initiated, discontinued or dose changed. Spacing administration by at least 2 hours may reduce the risk of interaction." assertion.
- drugbank:DB01432 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00500_DB01432 assertion.
- drugbank:DB00500 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00500_DB01432 assertion.